胸主动脉腔内修复术联合弓上血管血运重建与围术期缺血性卒中风险增加相关
基于血管质量倡议登记数据库(2015-2021年)的退行性动脉瘤择期胸主动脉腔内修复术(TEVAR)患者分析显示,主动脉弓动脉瘤患者术后30天缺血性卒中发生率高于降主动脉瘤患者(7.1% vs 2.9%,P=0.001),弓上血管腔内血运重建与卒中风险增加相关(RR 2.66,95%CI 1.06-6.70)。
要点
- 主动脉弓动脉瘤TEVAR术后30天缺血性卒中率高于降主动脉瘤(7.1% vs 2.9%,P=0.001)。
- 弓上血管腔内血运重建与TEVAR后缺血性卒中风险增加相关(RR 2.66,95%CI 1.06-6.70)。
- 年龄>79岁、功能依赖状态和手术时间也与TEVAR后缺血性卒中相关。
核心结论
- 与降主动脉瘤相比,主动脉弓动脉瘤患者TEVAR后缺血性卒中风险增加。
- 更近端的区域覆盖和弓上血管腔内介入与卒中风险增加相关。
- 作者认为,在行TEVAR联合弓上血管血运重建前,有必要做好充分的卒中预防准备。
研究设计与样本
- 回顾性查询血管质量倡议登记数据库(2015-2021年)中因退行性动脉瘤行择期TEVAR的病例。
- 共纳入3,072例患者,其中主动脉弓动脉瘤197例(6.4%),降主动脉瘤2,875例(93.6%)。
- 中位年龄73岁(四分位距67-79),男性占54.8%。
- 弓部动脉瘤组中,0区干预占27.4%,1区占22.8%,2区占49.8%。
- 采用多变量泊松回归评估患者、手术和医院层面卒中预测因素。
主要发现
- 总体30天卒中和死亡发生率分别为3.2%和3.8%。
- 卒中事件分布为双侧52.9%、左颈动脉20.7%、左椎基底动脉11.5%、右颈动脉9.2%、右椎基底动脉5.7%。
- 两组死亡率相似,但主动脉弓动脉瘤患者缺血性卒中率高于降主动脉瘤患者(7.1% vs 2.9%,P=0.001)。
- 与TEVAR后缺血性卒中相关的因素包括:年龄>79岁(RR 1.79,95%CI 1.08-2.98,对照<79岁)、功能依赖状态(RR 1.73,95%CI 1.07-2.78)、手术时间(RR 1.25,95%CI 1.15-1.36)、弓上血管血运重建的腔内介入(RR 2.66,95%CI 1.06-6.70,对照无介入)。
临床怎么用
- 作者认为,在行TEVAR联合弓上血管血运重建前,有必要做好充分的卒中预防准备。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Ischemic stroke is a devastating complication of thoracic endovascular aortic repair (TEVAR). This risk may be higher in more proximal aneurysms that require arch manipulation. The purpose of this study is to (1) describe 30-day stroke and death rates in patients undergoing TEVAR, (2) compare stroke rates in patients undergoing TEVAR for arch versus descending aneurysm pathology, and (3) identify predictive factors associated with stroke after TEVAR. METHODS: The Vascular Quality Initiative registry was queried (2015-2021) for TEVAR procedures performed for degenerative aneurysms. Our primary outcomes were any stroke or death at 30 days. Patient-, procedure-, and hospital-level predictors of stroke were assessed using multivariable Poisson regression. RESULTS: Among 3,072 patients with degenerative aneurysms (197 [6.4%] arch versus 2,875 [93.6%] descending) treated with elective TEVAR, the median age was 73 years (interquartile range 67-79) and 54.8% were male. Within the arch aneurysm group, there were 27.4% zone 0, 22.8% zone 1, and 49.8% zone 2 interventions. Overall 30-day stroke and death rates were 3.2% and 3.8%. The distribution of stroke events was bilateral (52.9%), left carotid (20.7%), left vertebrobasilar (11.5%), right carotid (9.2%), and right vertebrobasilar (5.7%). Although mortality was similar between groups, the rate of ischemic stroke was higher for patients undergoing TEVAR for arch aneurysm versus descending aneurysms (7.1% arch versus 2.9% descending, P = 0.001). Factors that were associated with ischemic stroke after TEVAR included age (>79 years, relative risk [RR] 1.79, 95% confidence interval [CI] 1.08-2.98 vs. <79 years), dependent functional status (RR 1.73, 95% CI 1.07-2.78), procedural time (RR 1.25, 95% CI 1.15-1.36), and endovascular intervention for supra-aortic trunk revascularization (RR 2.66, 95% CI 1.06-6.70 versus no intervention). CONCLUSIONS: Ischemic stroke risk after TEVAR was increased for arch aneurysms compared to descending aneurysms. More proximal zone coverage and endovascular interventions on the supra-aortic trunks were associated with increasing risk for stroke. Adequate preparation for stroke prevention is necessary prior to TEVAR with supra-aortic trunk revascularization.
引用
- Li RD, Chia MC, Eskandari MK, et al. Thoracic Endovascular Aortic Repair with Supra-Aortic Trunk Revascularization is Associated with Increased Risk of Periprocedural Ischemic Stroke. Ann Vasc Surg. 2022. PMID: 35835381. doi:10.1016/j.avsg.2022.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。